Ethinyl Estradiol

From DrugPedia: A Wikipedia for Drug discovery

(Difference between revisions)
Jump to: navigation, search
m
m (1 revision)
Line 1: Line 1:
 +
'''Ethinyl Estradiol'''
 +
'''Pubchem(5991)'''
 +
A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES.
 +
 +
'''KEGG PATHWAY'''(C07534,D00554)
-
<table align='right' border=1>
+
'''Category'''  Hormone
-
<tr><td>
+
    
-
<jmol><jmolApplet>
+
'''Activity''' Estrogen
-
<size>200</size>
+
-
<script>spin on;color atoms amino;</script>
+
-
<uploadedFileContents>NPH164.SDF</uploadedFileContents>
+
-
<color>black</color>
+
-
</jmolApplet>
+
-
</jmol>
+
-
</td></tr></table>
+
-
==Description==
+
-
A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl   substitution. It has high estrogenic potency when administered orally,  and is often used as the estrogenic component in ORAL  CONTRACEPTIVES.
+
-
==General Properties==
+
-
<b>*Molecular Weight</b>
+
{| border="1;width:100%; height:200px;style=text-align:center"
 +
|+'''Table I:'''
 +
|-
 +
! style="background:brown; color:white" |Physical Property
 +
! style="background:brown; color:white" |Value
 +
! style="background:brown; color:white" |Units
 +
! style="background:brown; color:white" |Temp (deg C)
 +
! style="background:brown; color:white" |Source
 +
|-
 +
|Melting Point
 +
|183
 +
|deg C  
 +
|EXP
 +
|-
 +
|log P (octanol-water)
 +
|3.67
 +
|(none)  
 +
|EXP
 +
|-
 +
|Water Solubility
 +
|11.3
 +
|mg/L
 +
|27
 +
|EXP
 +
|-
 +
|Vapor Pressure
 +
|2.67E-09
 +
|mm Hg
 +
|25
 +
|EST
 +
|-
 +
|Henry's Law Constant
 +
|7.94E-12
 +
|atm-m3/mole
 +
|25
 +
|EST
 +
|-
 +
|Atmospheric OH Rate Constant
 +
|1.25E-10
 +
|cm3/molecule-sec
 +
|25
 +
|EST
 +
|-
 +
|}
 +
{| border="1;width:100%; height:200px;style=text-align:center"
 +
|+'''Table I:'''
 +
|-
 +
! style="background:brown; color:white" |Organism
 +
! style="background:brown; color:white" |Test Type 
 +
! style="background:brown; color:white" |Route 
 +
! style="background:brown; color:white" |Reported Dose (Normalized Dose)
 +
! style="background:brown; color:white" |Effect
 +
! style="background:brown; color:white" |Source
 +
|-
 +
|mouse
 +
|LD50
 +
|intraperitoneal
 +
|250mg/kg (250mg/kg)
 +
|BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
-
296.4
+
BEHAVIORAL: ATAXIA
 +
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
 +
|Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18, Pg. 2583, 1990.
 +
|-
 +
|mouse
 +
|LD50
 +
|oral
 +
|950mg/kg (950mg/kg)
 +
|  
 +
|Drugs in Japan Vol. -, Pg. 222, 1995.
 +
|-
 +
|mouse
 +
|LD50
 +
|subcutaneous
 +
|> 3gm/kg (3000mg/kg)
 +
|BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
 +
|BLOOD: HEMORRHAGE Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18, Pg. 2583, 1990.
 +
|-
 +
|rat
 +
|LD50
 +
|intraperitoneal
 +
|471mg/kg (471mg/kg)
 +
|BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
-
<b>*Molecular Formula</b>
+
BEHAVIORAL: ATAXIA
 +
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
 +
|Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18, Pg. 2583, 1990.
 +
|-
 +
|rat
 +
|LD50
 +
|oral
 +
|960mg/kg (960mg/kg)
 +
 +
|Drugs in Japan Vol. -, Pg. 222, 1995.
 +
|-
 +
|rat
 +
|LD50
 +
|subcutaneous
 +
|> 2gm/kg (2000mg/kg)
 +
|BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
-
C<sub>2</sub><sub>0</sub>H<sub>2</sub><sub>4</sub>O<sub>2</sub>
+
BLOOD: HEMORRHAGE
 +
|Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18, Pg. 2583, 1990.
 +
|-
 +
|women
 +
|TDLo
 +
|oral
 +
|21mg/kg/21D-I (21mg/kg)
 +
|LUNGS, THORAX, OR RESPIRATION: DYSPNEA
-
<b>*IUPAC NAME</b>
+
GASTROINTESTINAL: NAUSEA OR VOMITING
-
 
+
|Lancet. Vol. 1, Pg. 1479, 1973.
-
(8R,9S,13S,14S,17R)-17-ethynyl-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17-diol
+
|-
-
 
+
|}
-
<b>*Canonical Smiles</b>
+
-
 
+
-
CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O
+
-
 
+
-
<b>*Isomeric Smiles</b>
+
-
 
+
-
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)O
+
-
 
+
-
 
+
-
==PhysioChemical Properties==
+
-
 
+
-
<b>*Melting Point</b>
+
-
 
+
-
183(EXP)
+
-
 
+
-
<b>*LogP</b>
+
-
 
+
-
3.67(EXP)
+
-
 
+
-
<b>*Water Solubility</b>
+
-
 
+
-
11.3(EXP) at 27C
+
-
 
+
-
==External Links==
+
-
*[http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5991]Pubchem
+
-
*[http://www.genome.jp/dbget-bin/www_bget?compound+C07534]KEGG Compound
+
-
*[http://www.genome.jp/dbget-bin/www_bget?drug+D00554]KEGG Drug
+
-
*[http://www.drugbank.ca/drugs/DB00977]Drugbank
+
-
 
+
-
[[Categories:Hormones]]
+

Revision as of 07:12, 13 February 2009

Ethinyl Estradiol Pubchem(5991)

A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES.

KEGG PATHWAY(C07534,D00554)

Category Hormone

Activity Estrogen

Table I:
Physical Property Value Units Temp (deg C) Source
Melting Point 183 deg C EXP
log P (octanol-water) 3.67 (none) EXP
Water Solubility 11.3 mg/L 27 EXP
Vapor Pressure 2.67E-09 mm Hg 25 EST
Henry's Law Constant 7.94E-12 atm-m3/mole 25 EST
Atmospheric OH Rate Constant 1.25E-10 cm3/molecule-sec 25 EST
Table I:
Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 250mg/kg (250mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: ATAXIA KIDNEY, URETER, AND BLADDER: OTHER CHANGES

Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18, Pg. 2583, 1990.
mouse LD50 oral 950mg/kg (950mg/kg) Drugs in Japan Vol. -, Pg. 222, 1995.
mouse LD50 subcutaneous > 3gm/kg (3000mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BLOOD: HEMORRHAGE Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18, Pg. 2583, 1990.
rat LD50 intraperitoneal 471mg/kg (471mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: ATAXIA KIDNEY, URETER, AND BLADDER: OTHER CHANGES

Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18, Pg. 2583, 1990.
rat LD50 oral 960mg/kg (960mg/kg) Drugs in Japan Vol. -, Pg. 222, 1995.
rat LD50 subcutaneous > 2gm/kg (2000mg/kg) BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)

BLOOD: HEMORRHAGE

Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 18, Pg. 2583, 1990.
women TDLo oral 21mg/kg/21D-I (21mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

GASTROINTESTINAL: NAUSEA OR VOMITING

Lancet. Vol. 1, Pg. 1479, 1973.